COVID-Related Thrombosis and Overall Implications Related to Percutaneous Interventions

Abstract

The SARS-COV-2/ COVID-19 pandemic created unique, once in a lifetime challenges for healthcare workers across the globe. One of the challenges specific to interventional radiology was the increased incidence of vascular thrombosis leading to urgent and emergent clinical patient management issues. Limited healthcare resources and complex clinical presentations required innovative solutions, and workflows to manage the increased burden on the healthcare providers.

Keywords

thrombosis - COVID-19 - peripheral vascular disease

Publication History

Article published online:
20 December 2022

• References

• 1 Driggin E, Madhavan MV, Bikdeli B. et al. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol 2020; 75 (18) 2352-2371
• 2 Gerhard-Herman MD, Gornik HL, Barrett C. et al. 2016 AHA/ACC Guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol 2017; 69 (11) e71-e126
• 3 Patel P, Yu Y, Zia S, Padberg F, Curi M, Huang J. Systemic thrombolysis as initial treatment of COVID-19 associated acute aortoiliac and lower extremity arterial thrombosis. Ann Vasc Surg 2021; 70: 297-301
• 4 Information for Healthcare Professionals about Coronavirus (COVID-19). Updated December 13, 2020. Accessed October 5, 2022 at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/index.html
• 5 Poissy J, Goutay J, Caplan M. et al; Lille ICU Haemostasis COVID-19 Group. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation 2020; 142 (02) 184-186
• 6 Klok FA, Kruip MJHA, van der Meer NJM. et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res 2020; 191: 148-150
• 7 Goyal P, Choi JJ, Pinheiro LC. et al. Clinical characteristics of COVID-19 in New York City. N Engl J Med 2020; 382 (24) 2372-2374
• 8 Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost 2020; 18 (06) 1421-1424
• 9 Middeldorp S, Coppens M, van Haaps TF. et al. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost 2020; 18 (08) 1995-2002
• 10 Wang T, Chen R, Liu C. et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol 2020; 7 (05) e362-e363
• 11 Moores LK, Tritschler T, Brosnahan S. et al. Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19. CHEST Guideline and Expert Panel Report Chest 2020; 158 (03) 1143-1163
• 12 Giri J, Sista AK, Weinberg I. et al. Interventional therapies for acute pulmonary embolism: current status and principles for the development of novel evidence: a scientific statement from the American Heart Association. Circulation 2019; 140 (20) e774-e801